It Takes a Village:

Collaborating to make a difference in the lives of people with cancer


Despite new discoveries and improvements in the care of people with bladder cancer, there's still a significant need for scientific advancement in this area. At Merck, we have made it our mission to help address this need through innovative research.

Bladder cancers are divided into various types depending on the type of cells that become cancerous. The most common type is urothelial (transitional cell) carcinoma, which most often starts in the urothelial cells lining the inside of the bladder.

If not caught early enough, bladder cancer can become invasive and spread to other organs, sometimes leading to a radical cystectomy (bladder removal).

Our bladder cancer team has dedicated itself to researching the unmet needs of patients. Working across functions - and continents - the team has worked tirelessly and collaboratively to uncover solutions and help patients with bladder cancer.

We invited members of the team to share perspective on what drives them to deliver on Merck’s mission.

Tara Frenkl
dist. scientist, Clinical Research
Oncology Clinical Development

As a urologist, I have cared for patients with bladder cancer and witnessed the need for additional treatments to help improve lives and prevent cystectomies. I am surrounded by talented experts working collaboratively toward delivering on our important mission of helping save lives. The work we do impacts patients and families around the world, and I am committed to making a difference in their journeys.

Jeffrey N. Stuart, Ph.D., RAC
executive director
Global Regulatory Affairs

We put patients at the center of everything we do. Our vision focuses on collaboration and empowerment to achieve global regulatory milestones. We do this through strong strategic acumen, high quality documentation, and timely deliverables. As a high-performing global regulatory team that frequently integrates diverse styles, ideas and perspectives, we champion courage and flexibility to do what is best for patients on the front lines of fighting cancer.

Amy Johnson
associate director
Project Management, Oncology

Patients are always the primary focus of our work. The team works tirelessly toward one common goal - to bring treatment options to patients around the world with bladder cancer. We are all committed to do everything we can to help save patients' lives.